Obesity is not a confounding factor for performing autonomic function tests in individuals with diabetes mellitus

Diabetes, Obesity and Metabolism

Volumn 4, Issue 2, 2002, Pages 113-117

  Maser, R E ^a,b   Lenhard, M J ^b  

^a UNIVERSITY OF DELAWARE   (United States)

^b CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

Cardiovascular autonomic neuropathy; Heart rate variability; RR variation

Indexed keywords

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; AUTONOMIC NEUROPATHY; BODY MASS; BODY WEIGHT; BREATHING PATTERN; BREATHING RATE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CLINICAL STUDY; CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAPHY MONITORING; EXERCISE TOLERANCE; FEMALE; FUNCTION TEST; HUMAN; HYPERPNEA; INSULIN DEPENDENT DIABETES MELLITUS; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORBID OBESITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REPRODUCIBILITY; RISK FACTOR; VALSALVA MANEUVER;

EID: 0036254530     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2002.00188.x     Document Type: Article

References (18)

1. Cardiovascular autonomic neuropathy testing in patients with diabetes
2. Diabetic cardiovascular autonomic neuropathy: Prognosis, diagnosis and treatment
3. Cardiac autonomic dysfunction in obese subjects
4. Body fat and the activity of the autonomic nervous system
5. Cardiovascular autonomic nervous system tests: Determination of normative values and effect of confounding variables
6. Impact of obesity on neuropathic late complications in NIDDM
7. Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM)
8. Autonomic neuropathy in non-insulin dependent (type II) diabetes mellitus. Possible influence of obesity
9. Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes
10. Autonomic neuropathy in non-insulin-dependent diabetic patients: Correlation with age, sex, duration and metabolic control of diabetes
11. Assessment: Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
12. Cardiovascular autonomic reflex tests: Normal responses and age-related reference values
13. Cardiovascular autonomic neuropathy. Where have we been and where are we going?
14. Diabetic autonomic neuropathy-part I. Autonomic nervous system data analysis by a computerized central unit in a multicenter trial
15. Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man
16. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy
17. RR-variation: The autonomic test of choice in diabetes
18. Diabetic autonomic neuropathy and cardiovascular risk